<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">IL-10 mediates plasmacytosis-associated immunodeficiency by inhibiting complementmediated neutrophil migration</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-12-02">December 2, 2015.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Upasana</forename><surname>Kulkarni</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Christian</forename><forename type="middle">M</forename><surname>Karsten</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Thomas</forename><surname>Kohler</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Sven</forename><surname>Hammerschmidt</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Kurt</forename><surname>Bommert</surname></persName>
						</author>
						<author>
							<persName><roleName>MS</roleName><forename type="first">Benjamin</forename><surname>Tiburzy</surname></persName>
						</author>
						<author>
							<persName><roleName>MS</roleName><forename type="first">Lingzhang</forename><surname>Meng</surname></persName>
						</author>
						<author>
							<persName><roleName>MS</roleName><forename type="first">Lara</forename><surname>Thieme</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Andreas</forename><surname>Recke</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ralf</forename><forename type="middle">J</forename><surname>Ludwig</surname></persName>
						</author>
						<author>
							<persName><roleName>MS</roleName><forename type="first">Karolin</forename><surname>Pollok</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Kathrin</forename><surname>Kalies</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Bjarne</forename><surname>Bogen</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Institute of Immunology</orgName>
								<orgName type="department" key="dep2">Departments of i Internal Medicine III</orgName>
								<orgName type="laboratory">the Centre for Immune Regulation and KG Jebsen Centre for Influenza Vaccine Research</orgName>
								<orgName type="institution" key="instit1">University of Oslo</orgName>
								<orgName type="institution" key="instit2">Oslo University Hospital</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Martin</forename><surname>Boettcher</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Thomas</forename><surname>Kamradt</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Anja</forename><forename type="middle">E</forename><surname>Hauser</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Christian</forename><surname>Langer</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Markus</forename><surname>Huber-Lang</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Hand, Plastic and Reconstruction Surgery</orgName>
								<orgName type="department" key="dep2">Immunology and Rheumatology</orgName>
								<orgName type="department" key="dep3">Department of Internal Medicine</orgName>
								<orgName type="department" key="dep4">Department of Medicine</orgName>
								<orgName type="department" key="dep5">Division of Immunobiology</orgName>
								<orgName type="department" key="dep6">Cincinnati Children&apos;s Hospital Medical Center</orgName>
								<orgName type="institution" key="instit1">Orthopaedic Trauma</orgName>
								<orgName type="institution" key="instit2">University of Ulm; k the Division of Allergy</orgName>
								<orgName type="institution" key="instit3">University of Cincinnati College of Medicine</orgName>
								<orgName type="institution" key="instit4">Cincinnati Veterans Affairs Medical Center</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Fred</forename><forename type="middle">D</forename><surname>Finkelman</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">J€</forename><surname>Org K€ Ohl</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">David</forename><forename type="middle">M</forename><surname>Wong</surname></persName>
						</author>
						<author role="corresp">
							<persName><roleName>PhD</roleName><forename type="first">Rudolf</forename><surname>Armin Manz</surname></persName>
							<email>rudolf.manz@uksh.de</email>
						</author>
						<author>
							<persName><forename type="first">Squibb</forename><forename type="middle">F D</forename><surname>Finkelman</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">L€ ubeck</orgName>
								<address>
									<addrLine>W€ urzburg</addrLine>
									<settlement>Jena, Greifswald, Berlin, Ulm, Germany, Oslo, Norway, Cincinnati</settlement>
									<region>Ohio</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Institute of Experimental Dermatology</orgName>
								<orgName type="department" key="dep2">Institute of Anatomy</orgName>
								<orgName type="department" key="dep3">Institute of Immunology</orgName>
								<orgName type="department" key="dep4">Department Genetics of Microorganisms</orgName>
								<orgName type="institution" key="instit1">Institute for Systemic Inflammation Research</orgName>
								<orgName type="institution" key="instit2">University of L€ ubeck</orgName>
								<orgName type="institution" key="instit3">University Hospital Jena</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Interfaculty Institute for Genetics and Functional Genomics</orgName>
								<orgName type="department" key="dep2">Comprehensive Cancer Centre Mainfranken</orgName>
								<orgName type="department" key="dep3">Department of Rheumatology, and German Arthritis Research Center</orgName>
								<orgName type="institution" key="instit1">University of Greifswald</orgName>
								<orgName type="institution" key="instit2">University Hospital W€ urzburg; f Charit e-University Medicine Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Institute for Systemic Inflammation Research</orgName>
								<orgName type="institution">University of L€ ubeck</orgName>
								<address>
									<addrLine>Ratzeburger Allee 160</addrLine>
									<postCode>23538 L€ ubeck</postCode>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">IL-10 mediates plasmacytosis-associated immunodeficiency by inhibiting complementmediated neutrophil migration</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-12-02">December 2, 2015.</date>
						</imprint>
					</monogr>
					<idno type="MD5">D2C0093E3DA0311163E4F02D8E502606</idno>
					<idno type="DOI">10.1016/j.jaci.2015.10.018</idno>
					<note type="submission">received support from DFG-KFO 21. Disclosure of potential conflict of interest: U. Kulkarni receives travel support from The Received for publication April 16, 2015; revised October 1, 2015; accepted for publication October 6, 2015.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:31+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Plasmacytosis</term>
					<term>IL-10</term>
					<term>immunodeficiency</term>
					<term>neutrophil</term>
					<term>inflammation</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Plasmacytosis (ie, an expansion of plasma cell populations to much greater than the homeostatic level) occurs in the context of various immune disorders and plasma cell neoplasia.</s><s>This condition is often associated with immunodeficiency that causes increased susceptibility to severe infections.</s><s>Yet a causative link between plasmacytosis and immunodeficiency has not been established.</s><s>Objective: Because recent studies have identified plasma cells as a relevant source of the immunosuppressive cytokine IL-10, we sought to investigate the role of IL-10 during conditions of polyclonal and neoplastic plasmacytosis for the regulation of immunity and its effect on inflammation and immunodeficiency.</s><s>Methods: We used flow cytometry, IL-10 reporter (Vert-X) and B cell-specific IL-10 knockout mice, migration assays, and antibody-mediated IL-10 receptor blockade to study plasmacytosis-associated IL-10 expression and its effect on inflammation and Streptococcus pneumoniae infection in mice.</s><s>ELISAwas used to quantify IL-10 levels in patients with myeloma.</s><s>Results: IL-10 production was a common feature of normal and neoplastic plasma cells in mice, and IL-10 levels increased with myeloma progression in patients.</s><s>IL-10 directly inhibited neutrophil migration toward the anaphylatoxin C5a and suppressed neutrophil-dependent inflammation in a murine model of autoimmune disease.</s><s>MOPC.315.BM murine myeloma leads to an increased incidence of bacterial infection in the airways, which was reversed after IL-10 receptor blockade.</s><s>Conclusion: We provide evidence that plasmacytosis-associated overexpression of IL-10 inhibits neutrophil migration and neutrophil-mediated inflammation but also promotes immunodeficiency.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>2]<ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref> Under physiologic conditions, plasma cell numbers are tightly regulated, not exceeding approximately 0.5% of all nucleated cells in lymphoid tissues. <ref type="bibr" target="#b5">6</ref></s><s>]<ref type="bibr" target="#b23">[24]</ref> In addition to their well-appreciated role as antibody factories, plasma cells also exhibit immunomodulatory functions.</s><s>For example, they provide negative feedback by suppressing Abbreviations used Foxp3: Forkhead box protein 3 GFP: Green fluorescent protein GMD: Goat anti-mouse IgD serum GST: Glutathione-S-transferase IC: Immune complex MM: Multiple myeloma SLE: Systemic lupus erythematosus Treg: Regulatory T T-follicular helper cells that are crucial for plasma cell generation in T-dependent immune reactions. <ref type="bibr" target="#b24">25</ref></s><s>Furthermore, IL-17 produced by CD138 hi plasma cells/plasmablasts mediates protective immunity against Trypanosoma cruzi infection. <ref type="bibr" target="#b25">26</ref></s><s>oreover, recent studies indicate that CD138 hi cells can be a major source of IL-10, <ref type="bibr" target="#b26">27</ref> which can control T cell-mediated inflammation in patients with experimental autoimmune encephalomyelitis. <ref type="bibr" target="#b27">28</ref></s><s>L-10 production has also been reported for human MM cell lines, <ref type="bibr" target="#b28">29</ref> and high serum IL-10 levels have been found in patients with SLE. <ref type="bibr" target="#b29">30</ref> However, increased IL-10 production has not been described as a cause of immunodeficiency in patients with MM or other conditions exhibiting plasmacytosis.</s></p><p><s>Defects in neutrophil functions contribute to the general immunodeficiency associated with SLE and MM. <ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b30">31</ref></s><s>Neutrophils are important innate effector cells <ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33</ref> crucial for protection against bacterial pathogens. <ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b34">35</ref></s><s>Consistently, bacterial infections are frequently observed in patients with SLE and myeloma. <ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23</ref></s><s>n the other hand, neutrophils drive the acute and chronic inflammation associated with autoimmune diseases. <ref type="bibr" target="#b35">36</ref></s><s>he complement fragment C5a, one of the most potent neutrophil chemoattractants, is formed by complement activation in response to immune complexes (ICs). <ref type="bibr" target="#b36">37</ref></s><s>For example, local activation of complement and neutrophil infiltration is necessary for the initiation of epidermolysis bullosa acquisita, an antibodymediated chronic autoimmune skin-blistering disease. <ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b38">39</ref></s><s>ccordingly, C5a receptor signaling in neutrophils drives the inflammatory response in the Arthus reaction, the prototypic local immune reaction mediated by acute IC deposition. <ref type="bibr" target="#b39">40,</ref><ref type="bibr" target="#b40">41</ref></s><s>ere we demonstrate that plasmacytosis-associated IL-10 limits neutrophil-mediated inflammation.</s><s>Additionally, we provide evidence that the price for this reduced inflammation is a deficiency in neutrophil function, causing increased susceptibility to severe bacterial infections.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS Mice</head><p><s>C57BL/6 and BALB/c mice were purchased from Charles River (Bar Harbor, Me).</s><s>IL-10 reporter (Vert-X), BALB/c forkhead box protein 3 (Foxp3) reporter (Foxp3 eGFP ), and CD19 Cre/IL-10 flox/flox mice and their littermate controls were bred at the animal facility of the University of L€ ubeck.</s><s>Experiments were performed at the animal facilities of the Universities of L€ ubeck and Greifswald.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Experimental epidermolysis bullosa acquisita and polyclonal plasmacytosis</head><p><s>Epidermolysis bullosa acquisita was induced by means of subcutaneous immunization and scored, as previously described. <ref type="bibr" target="#b41">42</ref></s><s>Autoreactive plasma cells were identified by means of flow cytometry, as previously described. <ref type="bibr" target="#b41">42</ref></s><s>or more information, see the Methods section in this article's Online Repository at www.jacionline.org.</s><s>Collagen VII (amino acids 757-967) was produced, as recently described. <ref type="bibr" target="#b41">42</ref></s><s>Collagen-specific serum antibodies were quantified by means of ELISA.</s><s>Plates were coated with 500 ng of collagen VII.</s><s>After blocking, wells were incubated with a 150-fold dilution of the serum samples for 60 minutes.</s><s>Detection was performed with biotinylated goat anti-mouse IgG antibody (SouthernBiotech, Birmingham, Ala), followed by streptavidin-coupled alkaline phosphatase (Roche Diagnostics, Mannheim, Germany) and ALP (Roche Diagnostics GmbH).</s><s>Polyclonal plasmacytosis was induced by means of intraperitoneal injection with 200 mL of goat-anti mouse IgD.</s><s>Some groups received anti-IL-10 receptor (clone IBI.3, a generous gift from DNAX, Palo Alto, Calif).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Murine myeloma</head><p><s>As previously described, <ref type="bibr" target="#b42">43</ref> murine myeloma was induced by means of intravenous injections of MOPC315.BM cells (5 3 10 5 cells) stably transfected with eGFP.</s><s>MOPC315.BM myeloma-specific anti-DNP IgA antibodies were quantified by means of ELISA.</s><s>Briefly, plates were coated with 10 mg/mL DNP-BSA/PBS (1 hour at room temperature).</s><s>Nonspecific binding was blocked with 1 mg/mL BSA/PBS.</s><s>Subsequently, sera were incubated for 1 hour at room temperature.</s><s>Detection was done with biotinylated goat anti mouse IgA (SouthernBiotech), followed by streptavidin-coupled alkaline phosphatase (Roche Diagnostics) and ALP (Roche Diagnostics).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>C5a-mediated peritoneal inflammation</head><p><s>Mice were injected intraperitoneally with goat anti-mouse IgD serum (GMD) or goat serum (0.2 mL) and 6 days later were injected (intraperitoneally) with anti-IL-10 receptor antibody (0.5 mg) or rat IgG.</s><s>One day later, mice were injected with C5a (200 nM, 100 mL, administered intraperitoneally).</s><s>After 4 to 5 hours, mice were killed, and neutrophil numbers in peritoneal lavage fluid were determined by means of flow cytometry.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Infection and bioluminescent optical imaging</head><p><s>BALB/c mice with or without plasmacytoma (MOPC315.BM) were infected intranasally with bioluminescent pneumococci (Streptococcus pneumoniae D39lux). <ref type="bibr" target="#b43">44</ref></s><s>For this purpose, pneumococci were cultured to the exponential phase (A 600 5 0.35) in THY medium supplemented with 10% heatinactivated FBS (Gibco by Life Technologies, Grand Island, NY) and centrifuged, after which the infection dose was adjusted to 5.0 3 10 8 colonyforming units in 20 mL.</s><s>Before intranasal infection, mice were anaesthetized by means of intraperitoneal injection of ketamine (Ketanest S; Pfizer Pharma, Karlsruhe, Germany) and xylazine (Rompun; Provet AG, Lyssach, Germany).</s><s>The bacterial suspension was administered intranasally.</s><s>Bioluminescent optical imaging with the IVIS Spectrum Imaging System (Caliper Life Sciences, Hopkinton, Mass) allowed monitoring of pneumococcal dissemination after intranasal infection. <ref type="bibr" target="#b44">45,</ref><ref type="bibr" target="#b45">46</ref></s><s>At prechosen time intervals after infection, mice were imaged for 1 minute to monitor dissemination of pneumococci.</s><s>A time series of the images was generated, and the bioluminescent intensity was determined by means of quantification of the total photon emission with the LivingImage 4.1 software package (Caliper Life Sciences).</s></p><p><s>For more information on antibodies, flow cytometry, ELISA, histology, statistics, and study approval, see the Methods section in this article's Online Repository.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p><s>Polyclonal and neoplastic plasmacytosis is associated with increased IL-10 production B lineage cells with a CD138 hi plasma cell/plasmablast phenotype can significantly contribute to IL-10 production and thereby control T cell-mediated autoimmune inflammation. <ref type="bibr" target="#b27">28</ref></s><s>ere, we first tested the possibility that plasmacytosis increases production of immunosuppressive IL-10.</s><s>This cytokine was detectable in sera from 6 of 8 patients with advanced myeloma.</s><s>In contrast, it was present only at a relatively low level in 1 of 7 healthy control subjects and undetectable in patients exhibiting monoclonal gammopathy of undetermined significance, a precursor state of MM, and patients with early diagnosed myeloma (Fig <ref type="figure" target="#fig_1">1, A</ref>).</s><s>This finding is in accordance with the notion that IL-10 is produced by a considerable proportion of plasma cell lines derived from patients with myeloma. <ref type="bibr" target="#b28">29</ref></s><s>atients with SLE, the best characterized autoimmune disease involving polyclonal plasmacytosis, also exhibit increased IL-10 levels. <ref type="bibr" target="#b29">30</ref></s><s>To investigate IL-10 expression during the course of polyclonal plasmacytosis, we induced a massive polyclonal plasma cell response by injecting Vert-X mice with GMD. <ref type="bibr" target="#b46">47</ref></s><s>In this mouse model enhanced green fluorescent protein (GFP) is expressed under control of the IL-10 promoter.</s><s>At day 7, GMD-injected mice had plasmacytosis and showed a considerable population of GFP 1 cells that had the B220 low CD138 hi phenotype characteristic of early plasma cells.</s><s>GMD-injected mice also showed a moderate increase in GFP 1 cell counts among CD4 1 T cells.</s><s>As shown in Foxp3 reporter mice, IL-10 1  <ref type="bibr" target="#b46">47</ref> showing that plasma cells are a major source for IL-10 in GMD-treated mice.</s><s>In accordance with the massive increase in GFP 1 cell numbers, GMD-induced plasmacytosis was associated with an at least 50-fold increase in serum IL-10 levels (Fig 1 <ref type="figure">, D</ref>).</s><s>Of note, serum IL-10 levels were less than the detection limit of 0.2 ng/mL of our ELISA, even in mice treated with GMD.</s><s>Therefore serum IL-10 levels were quantified by using an in vivo cytokine capture assay. <ref type="bibr" target="#b47">48</ref></s><s>D138 hi plasma cells generated in vitro after LPS stimulation of B cells from Vert-X mice exhibited uniform GFP expression.</s><s>To investigate whether GFP expression correlated with IL-10 protein production, at day 4 of culture, B cells and CD138 hi plasma cells were separated by means of fluorescence-activated cell sorting and cultured for another 16 hours.</s><s>Culture supernatants from CD138 hi plasma cells contained approximately 5-fold more IL-10 than supernatants of B cells isolated from the same primary LPS culture.</s><s>IL-10 production by plasma cells was further increased when IL-6 was added to the cultures (Fig 1 <ref type="figure">, E</ref>). Supernatants of the murine plasma cell line MOPC315.BM contained similar IL-10 levels (data not shown).</s></p><p><s>Together, these data show that IL-10 production is a common feature of normal and neoplastic plasma cells and that IL-10 levels increase with progression of polyclonal and neoplastic plasmacytosis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Plasmacytosis-mediated suppression of neutrophil migration depends on B lineage-derived IL-10</head><p><s>At the peak of GMD-induced plasmacytosis, an increase in neutrophil populations was observed in the spleen and bone marrow (Fig <ref type="figure" target="#fig_3">2, A</ref>).</s><s>Neutrophil numbers were also increased in these tissues but not in blood (see    <ref type="figure">C</ref>).</s><s>These data are consistent with previous findings that B lineage-derived IL-10 can promote IL-10 production by Foxp3 2 regulatory type 1 T cells. <ref type="bibr" target="#b48">49</ref></s><s>Together, these data indicate that under conditions of plasmacytosis, plasma cell-derived IL-10 suppresses neutrophil migration, either directly or through induction of IL-10 production by CD4 T cells.</s><s>However, the mere expansion of Foxp3 1 Treg cells did not affect neutrophil migration under these conditions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Experimental MOPC315.BM plasmacytosis results in an IL-10-mediated complete block of neutrophil migration and increased susceptibility to bacterial infection</head><p><s>Notably, patients with myeloma have increased susceptibility to bacterial infections, <ref type="bibr" target="#b17">18</ref> and neutrophils are crucial for controlling such infections in healthy subjects. <ref type="bibr" target="#b31">32</ref></s><s>Because IL-10 is produced by several human myeloma cell lines and by the murine MOPC315.BM plasmacytoma cells used in this study, we tested whether IL-10 suppresses neutrophil function in experimental plasmacytoma in vivo.</s><s>For this purpose, MOPC315.BM cells were injected into syngeneic BALB/c mice, resulting in a disease that closely resembles MM. <ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b49">50</ref> Mice were distributed into 2 groups showing similar levels of myeloma-specific serum protein and were subsequently injected with either anti-IL-10 receptor or control antibody 1 day before the final analysis.</s><s>C5a-induced neutrophil influx into the peritoneum was completely abolished in myeloma-bearing mice compared with that seen in control mice that did not receive myeloma cells.</s><s>Importantly, myeloma-mediated suppression of neutrophil migration was completely restored by IL-10 receptor blockade (Fig <ref type="figure" target="#fig_6">5, A</ref>).</s><s>Interestingly, mice with myeloma treated with anti-IL-10 receptor antibody showed increased neutrophil accumulation compared with mice without myeloma.</s><s>Moreover, IL-10 blockade also increased C5a-mediated neutrophil accumulation in the peritoneum in mice without myeloma (see Fig <ref type="figure" target="#fig_6">E5</ref> in this article's Online Repository at www.jacionline.</s><s>org).</s><s>This suggests that IL-10 downmodulates neutrophil migration already under physiologic conditions.</s><s>However, this effect is much more pronounced during plasmacytosis.</s></p><p><s>Neutrophils are important for controlling bacterial infections (eg, S pneumoniae), which can cause uncontrollable and lethal pneumonia in patients with myeloma.</s><s>Therefore we assessed whether plasmacytosis-associated IL-10 contributes to increased susceptibility to bacterial pneumonia in the MOPC315.BM myeloma model.</s><s>Similar to immunocompetent human subjects, otherwise healthy BALB/c mice were relatively resistant to S pneumoniae2induced pneumonia.</s><s>Accordingly, as measured by using bioluminescence, <ref type="bibr" target="#b43">44</ref> mice 24 hours after infection without myeloma did not show any visible bacterial load in the airways or lungs (0/12).</s><s>Two days after infection, these mice still showed little visible pneumonia (1/12; Fig 5 <ref type="figure">, B</ref>), suggesting that the moderate inhibition of IL-10-mediated neutrophil migration that was observed already under physiologic conditions does not result in susceptibility to bacterial infection.</s><s>In contrast, already at 24 hours, mice with myeloma showed an increased incidence of bacterial infection in the airways (3/12), and one of them had some bacteria in the lungs.</s><s>At 48 hours, airway infections in these 3 mice progressed to severe pneumonia, and in addition, 2 further mice of this group also had pneumonia at this time.</s><s>These results suggest that mice with MOPC315.BM myeloma exhibit an increased susceptibility to bacterial pneumonia similar to that observed in patients with myeloma.</s><s>However, injection of an IL-10 receptor-blocking antibody at the time of infection reduced the incidence of pneumonia back to the level seen in the group of mice without myeloma (1/12).</s><s>Of note, both groups that did not receive IL-10 receptor blocking antibodies received control antibodies instead to control for unspecific effects.</s><s>Hence increased IL-10 expression significantly contributes to faster progression of bacterial infection in the airways and higher incidence of bacterial load in the lungs as observed in the MOPC315.BM myeloma model.</s><s>Together, these results indicate that plasmacytosis-associated overexpression of IL-10 can contribute considerably to neutrophil dysfunction and increased susceptibility to infection.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>High IL-10 concentrations directly suppress neutrophil migration toward C5a</head><p><s>In the experiments described above, neutrophil migration was directly induced by injection of the neutrophil attractant C5a, excluding indirect effects of IL-10 through reduction of inflammatory chemokine levels.</s><s>This finding suggests that plasmacytosis-associated IL-10 directly suppresses C5amediated neutrophil migration.</s><s>To investigate this further, we determined the effect of IL-10 on C5a-mediated neutrophil migration in vitro.</s><s>Although IL-10 concentrations of up to 12 ng/mL showed no effect, a concentration-dependent inhibition of neutrophil migration was observed at higher concentrations (Fig <ref type="figure">6, A</ref>).</s><s>Also, neutrophil migration was inhibited after 45 minutes of coculture of neutrophils with either purified plasma cells or murine MOPC315.BM plasmacytoma cells.</s><s>This effect was reversed by anti-IL-10 receptor antibody treatment (Fig <ref type="figure">6,  B</ref>).</s><s>These results indicate that IL-10 concentrations in the vicinity of plasma cells reach levels sufficient to inhibit neutrophil migration.</s><s>Despite this, IL-10 concentrations in plasma cell culture supernatants were less than 0.5 ng/mL, which is insufficient to inhibit neutrophil migration to C5a.</s><s>Of note, sera from patients with myeloma and sera from mice inoculated with MOPC315.BM plasmacytoma cells also contained concentrations of IL-10 much less than those required to inhibit neutrophil migration (data not shown).</s></p><p><s>Together, these data might suggest that plasmacytosisassociated inhibition of neutrophil migration in vivo takes place in tissues but not in the circulation, most likely in the vicinity of IL-10-secreting cells.</s><s>Bone marrow and splenic red pulp are important reservoirs for both plasma cells and neutrophils. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b32">33</ref></s><s>istologic observations confirmed that GMD-induced plasma cells, as well as MOPC315.BM murine plasmacytoma cells, often colocalize with neutrophils (Fig <ref type="figure" target="#fig_7">7</ref>), as has been described for other experimental systems. <ref type="bibr" target="#b50">51,</ref><ref type="bibr" target="#b51">52</ref></s><s>These data support a model in which IL-10-producing cells must be close to neutrophils to block complement-mediated neutrophil activation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IL-10 expressed during polyclonal plasmacytosis suppresses neutrophil-dependent autoimmune skin blistering disease</head><p><s>A recent study showed that plasma cell-derived IL-10 can block T cell-mediated autoimmune inflammation. <ref type="bibr" target="#b27">28</ref></s><s>The data presented here led us to speculate that a massive plasma cell response might be able to suppress neutrophil-dependent inflammation through IL-10.</s><s>C5a generated as a result of IC-mediated complement activation is a major neutrophil chemoattractant and is crucial for the induction of inflammation in many autoantibody-driven diseases, including epidermolysis bullosa acquisita, an autoimmune blistering disease of the skin mediated by collagen type VII-specific autoantibodies. <ref type="bibr" target="#b41">42</ref></s><s>Neutrophils are key players during the effector phase of this disease and are required to induce skin inflammation. <ref type="bibr" target="#b37">38</ref></s><s>Experimental epidermolysis bullosa acquisita does not involve plasmacytosis but is driven by an autoreactive plasma cell response restricted to the lymph nodes. <ref type="bibr" target="#b41">42</ref></s><s>Therefore this model allowed us to test the antiinflammatory potential of experimentally induced plasmacytosis on antibody-induced and neutrophil-mediated inflammation.</s></p><p><s>Disease was initiated by a single injection of the autoantigen collagen VII fused to glutathione-S-transferase (GST; collagen VII-GST).</s><s>The type VII collagen-specific autoreactive plasma cell response reaches its peak level 2 weeks after immunization, but skin inflammation does not start before week 4 to 5 after immunization. <ref type="bibr" target="#b41">42,</ref><ref type="bibr" target="#b52">53</ref></s><s>After the start of skin inflammation, plasmacytosis was induced by injection of GMD (Fig 8 <ref type="figure">, A</ref>). GMD-treated mice were protected from skin inflammation and neutrophil infiltration for at least another 3 weeks.</s><s>Suppression of epidermolysis bullosa acquisita skin inflammation was abrogated by means of coinjection of a neutralizing IL-10 receptor antibody (Fig 8 <ref type="figure">, B</ref>).</s><s>Despite its anti-inflammatory effect, GMD treatment neither reduced the numbers of autoreactive collagen VII-GST-specific plasma cells nor type VII collagen-specific autoantibodies that trigger epidermolysis bullosa acquisita skin inflammation (Fig 8 <ref type="figure">, C and D</ref>).</s><s>Hence plasmacytosis-associated IL-10 is sufficient to prevent the development of an autoantibody-initiated and neutrophilmediated inflammation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>Recent studies identified plasma cells as a relevant source of IL-10 that can control T cell-mediated inflammation. <ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b27">28</ref></s><s>The present study extends these findings and demonstrates that polyclonal and neoplastic plasmacytosis-associated IL-10 mediates suppression of effective neutrophil function.</s><s>Even moderate GMD-induced polyclonal plasmacytosis was sufficient to block neutrophil-mediated inflammation and pathophysiology in an autoimmune setting, whereas neutrophil migration was completely blocked in the MOPC315.BM myeloma model, in which plasma cells persist longer and in greater numbers than in GMD-immunized mice.</s><s>Moreover, in accordance with the complete block of IL-10-mediated neutrophil migration, myeloma-associated IL-10 mediated increased susceptibility to bacterial pneumonia.</s></p><p><s>In contrast to the effect of IL-10 on migration to other chemoattractants, its effect on neutrophil migration to C5a was not widely studied.</s><s>Vicioso et al <ref type="bibr" target="#b53">54</ref> found that IL-10 concentrations that block neutrophil migration to IL-8 are not sufficient to block migration to C5a and suggest that IL-10 is generally a modest inhibitor of neutrophil chemotaxis.</s><s>On the basis of their in vitro studies, these authors conclude that the accumulation of phagocytes at infection sites would not be significantly affected by IL-10.</s><s>Indeed, the present study suggests that relatively high IL-10 concentrations are required to block neutrophil migration to C5a.</s><s>Accordingly, the moderate effects of IL-10 on neutrophil migration observed under physiologic conditions did not result in susceptibility to bacterial pneumonia.</s><s>However, increased IL-10 production associated with plasmacytosis led to a considerable dysfunction of neutrophil migration and increased susceptibility to bacterial infection.</s></p><p><s>We propose that the IL-10-dependent mechanism identified here could be relevant under the following conditions: it can (1) limit antibody/IC-mediated inflammation in autoimmune and infectious diseases that are associated with plasmacytosis, such as autoimmune myelofibrosis, autoimmune hepatitis, SLE, <ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref> and malaria and schistosomiasis <ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref><ref type="bibr" target="#b56">[57]</ref> and (2) contribute to the immunodeficiency of patients with MM.</s></p><p><s>IC-mediated inflammation frequently occurs in patients with severe chronic infections <ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref><ref type="bibr" target="#b56">[57]</ref><ref type="bibr" target="#b57">[58]</ref><ref type="bibr" target="#b58">[59]</ref> as a result of increasing numbers of antibody-secreting plasma cells.</s><s>In this setting the anti-inflammatory properties of plasmacytosis-associated IL-10 might limit IC/neutrophil-mediated inflammation without affecting protective functions of antibodies, such as microbe immobilization, toxin neutralization, and induction of complement-mediated pathogen opsonization and lysis.</s></p><p><s>Among the plasmacytosis-associated autoimmune conditions, SLE resembles the best-known disease.</s><s>Autoantibodies are often present in sera of patients with SLE years before the clinical onset of disease. <ref type="bibr" target="#b59">60</ref></s><s>The anti-inflammatory pathway induced by plasmacytosis-associated IL-10 might contribute to delayed onset of lupus immunopathology.</s><s>Support for this idea comes from Lyn-deficient mice, which exhibit B cell-intrinsic hyperreactivity that leads to uncontrolled plasma cell formation, autoantibody production, and development of a lupus-like disease.</s><s>In this model B lineage-derived IL-10 was shown to reduce lupus nephritis development, <ref type="bibr" target="#b60">61</ref> and among B lineage cells, CD138 1 plasma cells were described as a major source of this cytokine. <ref type="bibr" target="#b60">61</ref></s><s>n contrast, B lineage-derived IL-10 does not inhibit autoimmunity in MRL.Fas(lpr) mice. <ref type="bibr" target="#b61">62</ref></s><s>However, in contrast to other models and patients with SLE, <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b62">63</ref> lupus in the MRL.Fas model is mainly driven by an uncontrolled T-cell response rather than by B-cell hyperreactivity. <ref type="bibr" target="#b63">64</ref></s><s>lasmacytosis-induced deficiency in neutrophil function seems also to increase the risk of infection.</s><s>Indeed, deficiencies in neutrophil functions, including migration, have been reported in patients with diseases associated with plasmacytosis, such as MM and SLE. <ref type="bibr" target="#b21">22</ref></s><s>Of note, neutrophils are required to elicit an efficient immune defense against gram-positive bacteria, which are the most frequent cause of severe infections in patients with both diseases. <ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23</ref></s><s>The results presented in this study might encourage studies aimed at probing blockade of the IL-10 receptor signaling pathway as a novel strategy to improve immune dysfunction and reduce severe infections in patients with MM and other diseases associated with plasmacytosis.</s></p><p><s>Activated B cells and plasma cells might also modulate inflammation through mechanisms other than IL-10.</s><s><ref type="bibr" target="#b64">[65]</ref><ref type="bibr" target="#b65">[66]</ref><ref type="bibr" target="#b66">[67]</ref> Hence the GMD-activated B cells and MOPC315.BM myeloma plasma cells used in this study might influence immune responses and inflammatory processes in multiple ways.</s><s>Nevertheless, our data indicate that IL-10 production is a key immunosuppressive factor and that blockade of the IL-10 signaling pathway might be useful to prevent plasmacytosis-associated susceptibility to infections.</s></p><p><s>The data presented here describe a novel IL-10-dependent mechanism that inhibits neutrophil migration and shows that this is relevant under conditions of plasmacytosis.</s><s>IL-10 produced by other cell types during immune responses or even under homeostatic conditions might also control neutrophil function.</s><s>The data presented here suggest that IL-10 might need to be present in the vicinity of neutrophils rather than acting systemically to suppress neutrophil migration.</s><s>Hence place and time of IL-10 production might determine its effect on neutrophil function.</s><s>However, this issue remains to be elucidated.</s></p><p><s>In addition to the direct inhibitory effect of IL-10 on neutrophil migration, IL-10 has many other anti-inflammatory effects, such as blockade of neutrophil activation and degranulation and inhibition of inflammatory chemokines and T cells, <ref type="bibr" target="#b67">68,</ref><ref type="bibr" target="#b68">69</ref> suggesting that plasmacytosis-associated IL-10 can suppress inflammation and protective immunity at multiple levels.</s><s>Nevertheless, neutrophil infiltration is a prerequisite for local tissue destruction by these important innate effector cells. <ref type="bibr" target="#b32">33</ref></s><s>ence the direct inhibitory effect of IL-10 on neutrophil migration toward C5a could be a key mechanism for limiting inflammation but also a mechanism that impairs innate immune defense.</s></p><p><s>In conclusion, this study provides evidence that ''normal'' and neoplastic plasma cell responses integrate an immunosuppressive IL-10 response, which can serve as a counterbalancing mechanism to limit harmful antibody/IC-mediated inflammation in case of a strong plasma cell response.</s><s>This protection comes at the price of the severe immunodeficiency that often accompanies diseases associated with plasmacytosis.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>Foxp3 1 CD4 1 and IL-10 1 Foxp3 2 CD4 1 cell populations were expanded by means of GMD treatment (see Fig E1 in this article's Online Repository at www.jacionline.org).</s><s>Hence plasmacytosis is associated with increased IL-10 production by plasma cells and CD4 T cells, including regulatory T (Treg) cells.</s><s>However, plasma cells accounted for the great majority of the increase in absolute GFP 1 cell numbers (Fig 1, B and C).</s><s>Cells other than B or T cells did not show increased GFP expression in GMD-treated mice (data not shown).</s><s>These data confirm those of Madan et al,</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIG 1 .</head><label>1</label><figDesc><div><p><s>FIG 1. Plasmacytosis is associated with increased IL-10 production.</s><s>A, Serum IL-10 levels of healthy control subjects and patients with monoclonal gammopathy of undetermined significance, early diagnosed myeloma (EDMM), and advanced myeloma (AM).</s><s>B, Cytometric analysis of GMD-, PBS-, or goat serum-treated IL-10 reporter mice.</s><s>C, GFP 1 cells on day 7. D, IL-10 serum levels.</s><s>E, IL-10 concentrations in supernatants from cultures with or without IL-6 (ANOVA).</s><s>**P &lt; .01 and ***P &lt; .001.</s></p></div></figDesc><graphic coords="3,110.27,65.59,368.36,389.48" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>Fig E2 in this article's Online Repository at www.jacionline.org).</s><s>Neutrophil frequencies in spleens were also increased in mice inoculated with MOPC315.BM plasmacytoma cells (Fig 2, B).</s><s>Complementmediated inflammation was mimicked by injecting the neutrophil attractant C5a into the peritoneum of mice at the peak of GMD-induced polyclonal plasmacytosis to assess the effect of high plasma cell loads on neutrophil migration.</s><s>As a positive control, C5a was injected into the peritoneum of mice that had been treated with goat serum.</s><s>As expected, C5a induced massive migration of neutrophils into the peritoneum (Fig 3, A).</s><s>Neutrophil frequencies in the peritoneum of GMD-treated mice were reduced by approximately 50% compared with those of goat serum-treated control mice.</s><s>The inhibitory effect in GMDtreated mice was reversed by injecting them with anti-IL-10 receptor antibody (Fig 3, A and B).</s><s>Neutrophil counts in blood</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIG 2 .</head><label>2</label><figDesc><div><p><s>FIG 2. Plasmacytosis is accompanied by changes in neutrophil frequencies.</s><s>A, Neutrophil frequencies at day 7 after induction of GMD-induced plasmacytosis compared with those in goat serum-treated control mice.</s><s>B, Neutrophil frequencies in spleens of mice with MOPC315.BM myeloma compared with those in control mice (Student t test).</s><s>**P &lt; .01.</s></p></div></figDesc><graphic coords="4,67.75,65.59,185.76,422.19" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>FIG 3 .</head><label>3</label><figDesc><div><p><s>FIG 3. Polyclonal plasmacytosis leads to IL-10-dependent suppression of neutrophil migration toward C5a.</s><s>Mice treated with GMD or goat serum (control) are shown.</s><s>One week later, C5a-mediated neutrophil influx was analyzed in the peritoneum.</s><s>Anti-IL-10 receptor (IL-10R) or control antibody was injected 1 day before analysis.</s><s>A, Representative fluorescence-activated cell sorting analysis.</s><s>B, Neutrophils in the peritoneum (ANOVA).</s><s>Ab, Antibody.</s><s>***P &lt; .001.</s></p></div></figDesc><graphic coords="4,302.68,65.59,235.86,311.02" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>FIG 4 .</head><label>4</label><figDesc><div><p><s>FIG 4. Polyclonal plasmacytosis suppresses neutrophil migration through B lineage-derived IL-10.</s><s>B cell-specific IL-10 knockout mice (KO) and littermate control animals (controls) received GMD or goat serum.</s><s>Analysis was performed 1 week later.</s><s>A, C5a-mediated neutrophil influx in the peritoneum (Kruskal-Wallis test).</s><s>B, IL-10 production in splenic CD4 cells (ANOVA).</s><s>C, Foxp3 1 CD4 1 cells (ANOVA).</s><s>*P &lt; .05 and ***P &lt; .001.</s><s>ns, Not significant.</s></p></div></figDesc><graphic coords="5,109.64,65.59,369.56,405.07" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>FIG 5 .</head><label>5</label><figDesc><div><p><s>FIG 5. Experimental myeloma results in IL-10-dependent suppression of neutrophil migration and increased susceptibility to pneumococcal pneumonia.</s><s>A, C5a-mediated neutrophil influx in mice with and without MOPC315.BM myeloma treated with anti-IL-10 receptor (IL-10R) or control antibody, as indicated.</s><s>B, Dissemination of pneumococci at 24 and 48 hours after infection after treatment with anti-IL-10 receptor antibody or control antibody, as indicated.</s><s>Ab, Antibody.</s><s>*P &lt; .05,</s><s>**P &lt; .01,</s><s>and ***P &lt; .001.</s></p></div></figDesc><graphic coords="6,42.41,65.59,236.39,519.82" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>FIG 7 .</head><label>7</label><figDesc><div><p><s>FIG 7. Histology: neutrophils and plasma cells are found in close proximity in vivo.</s><s>A, Murine spleens from GMD-treated mice stained for plasma cells (CD138, red), neutrophils (Ly6G, white), and 49-6-diamidino-2phenylindole dihydrochloride (DAPI; blue).</s><s>B, Femurs of mice bearing MOPC315.BM GFP 1 MOPC315.BM myeloma cells stained for neutrophils (Ly6G, white) and DAPI (blue).</s><s>MOPC315.BM cells were identified by using GFP (green).</s></p></div></figDesc><graphic coords="7,109.02,65.59,370.66,183.40" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>FIG 8 .</head><label>8</label><figDesc><div><p><s>FIG 8. Plasmacytosis-associated IL-10 blocks autoimmune skin inflammation.</s><s>Epidermolysis bullosa acquisita was induced by collagen VII-GST immunization.</s><s>At the start of inflammation 4 to 5 weeks later, mice were treated with GMD, anti-IL-10 receptor (IL-10R), or control antibody.</s><s>A, Experimental scheme.</s><s>B, Disease score by weeks (ANOVA).</s><s>C, Serum autoantibodies 3 weeks after GMD treatment.</s><s>D, Collagen VII-GST-specific plasma cells in lymph nodes.</s><s>Ab, Antibody; ns, not significant.</s><s>*P &lt; .05 and **P &lt; .01.</s></p></div></figDesc><graphic coords="8,107.32,65.59,366.46,495.61" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>FIG E1 .</head><label>E1</label><figDesc><div><p><s>FIG E1.</s><s>Polyclonal plasmacytosis augments IL-10 production in Foxp3 1 and Foxp3 2 CD4 T cells.</s><s>Foxp3 EGFP mice were treated with GMD or goat serum.</s><s>Seven days later, Foxp3 1 CD4 1 cells, IL-10 1 Foxp3 1 CD4 1 cells, and IL-10 1 Foxp3 2 CD4 1 cells were analyzed in spleens.</s><s>A, Representative flow cytometric data.</s><s>B, Graphs representing frequencies of Foxp3 1 Treg cells among CD4 1 T cells (left), IL-10 1 cells among Foxp3 1 CD4 1 Treg cells (middle), and IL-10 1 cells among Foxp3 2 CD4 1 cells (right).</s><s>C, Graphs representing total numbers of Foxp3 1 CD4 1 T cells (left), IL-10 1 Foxp3 1 CD4 1 cells (middle), IL-10 1 Foxp3 2 CD4 1 cells (right) in spleens.</s><s>Representative data are shown for one of 2 experiments.</s><s>*P &lt; .05,</s><s>**P &lt; .01,</s><s>and ***P &lt; .001,</s><s>2-tailed unpaired Student t test.</s><s>Each dot represents data from an individual mouse.</s><s>Data are expressed as means 6 SEMs.</s></p></div></figDesc><graphic coords="13,44.67,65.59,239.52,348.15" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="14,106.47,65.59,368.36,190.60" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOLMAY 2016</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL VOLUME 137, NUMBER 5</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>We thank Kathleen Kurwahn for her excellent technical assistance and Dr Axel Roers (University of Dresden) for providing CD19 Cre/IL-10 flox/ flox mice.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Clinical implications: Our results might encourage studies aimed at probing blockade of the IL-10 pathway as a novel strategy to reduce severe infections in patients with plasmacytosis-associated diseases.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS Flow cytometry</head><p><s>After blockade of Fc receptors with anti-CD16/CD32, single-cell suspensions were incubated for 15 minutes with conjugated antibodies against cell-surface markers.</s><s>Samples were analyzed with an LSRII (BD Biosciences, San Jose, Calif).</s><s>Data were analyzed with FlowJo software (TreeStar, Ashland, Ore).</s><s>Antibodies used were fluorescein isothiocyanatelabeled anti-IL-10 (clone JES5-16E3, eBioscience, San Diego, Calif); phycoerythrin-labeled anti-CD138 (clone 281-2, BD Biosciences PharMingen) and anti-Foxp3 (clone FJK-16s, eBioscience), Alexa Fluor 647-labeled anti-B220 (clone RA3.B2) and anti-GR1 (cone RB6-8C5, in-house production), APC-labeled anti-Ly6G (clone 1A8; BioLegend, Fell, Germany) and anti-CD19 (clone 1D3, eBioscience), and Alexa Fluor 405-labeled anti-CD4 (clone GK1.5, eBioscience) and anti-CD11b (clone M1/70.15.11, in-house production).</s><s>Collagen VII (amino acids 757-967) was produced, as recently described.</s><s><ref type="bibr">E1</ref> The protein was coupled to Alexa Fluor 700 and Alexa Fluor 488 (Life Technologies, Grand Island, NY), according to the manufacturer's protocols.</s></p><p><s>IL-10 ELISA and in vivo IL-10 capture assay IL-10 levels in supernatants of the murine B cell/plasma cell cultures were measured with a mouse IL-10 ELISA DuoSet kit (R&amp;D Systems, Minneapolis, Minn).</s><s>IL-10 levels in patients' serum were quantified by using the highly sensitive Human IL-10 Quantikine HS ELISA Kit (R&amp;D Systems).</s><s>Low levels of IL-10 in serum were quantified by using an in vivo IL-10 capture assay.</s><s>Mice were injected intraperitoneally with 10 mg of biotinylated anti-mouse IL-10 mAb (free of endotoxin) in 200 mL of 1% mouse serum in PBS.</s><s>Mice were bled 24 hours later, and the complex formed between the antibody and the cytokine was detected from serum by means of ELISA.</s><s>A 7-step 1:4 serial dilution of 100 ng/mL IL-10/anti-IL-10 antibody was performed on a 96-well microplate.</s><s>Similar dilution was performed for the serum samples.</s><s>Another 96-well high-binding microtiter plate was coated with 50 mL of coating antibody (concentration, 2 mg/mL in PBS) and incubated at 28C to 88C.</s><s>The plate was washed 4 times with washing buffer.</s><s>Twenty-five microliters of diluted serum samples and standard was added from the other 96-well plate to the coated plate in duplicates and incubated at room temperature for 30 minutes.</s><s>The plate was washed 6 times as before, and 25 mL of streptavidin-horseradish peroxidase (concentration, 50 ng/mL in dilution buffer) was added to each well.</s><s>The plate was incubated at room temperature for 20 minutes.</s><s>During this time, streptavidin-horseradish peroxidase binds to the biotinylated anti-IL-10 antibody.</s><s>The plate was washed 10 times, and development of the signal and data obtained was analyzed by comparing OD values.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Chemotaxis assay</head><p><s>Bone marrow-derived cells were resuspended in chemotaxis medium (Gey's Balanced Salt Solution containing 2% BSA) at a density of 6 3 10 6 cells/mL.</s><s>The chemoattractant C5a (10 28 mol/L) was diluted in chemotaxis medium, placed in the bottom wells of a Micro Boyden Chemotaxis Chamber (Neuro Probe, Gaithersburg, Md), and overlaid with a 3-mm polycarbonate membrane.</s><s>Then 50 mL of the cell suspension was placed in the top wells, and the chambers were incubated for 30 minutes at 378C.</s><s>Subsequently, membranes were removed, and cells on the bottom side of the membrane were stained with Diff-Quick.</s><s>Numbers of migrated cells in 5 highpower fields were counted and calculated by using computer-assisted light microscopy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Histology</head><p><s>Paraformaldehyde-fixed tissues were incubated for 3 days in increasing concentrations of 10%, 20%, and 30% sucrose; embedded in Tissue-Tek medium (Sakura Finetek, Torrance, Calif); and snap-frozen in liquid nitrogen.</s><s>Tissue sections (8 mm) were prepared with a microtome.</s><s>Nonspecific binding was blocked by PBS/10% rat serum and anti-CD16/CD32 (clone 2.4G2).</s><s>Staining with antibodies and secondary reagents was performed at room temperature for 30 to 60 minutes.</s><s>Staining reagents were goat anti-GFPfluorescein isothiocyanate (Rockland Immunochemicals Inc, Limerick, Pa), donkey anti-goat IgG-Alex Fluor 488 (Molecular Probes, Eugene, Ore), APClabeled anti-Ly6G (clone 1A8, BioLegend), and phycoerythrin-labeled anti-CD138 (clone 281-2, BD).</s><s>Sections were analyzed by means of confocal microscopy with an Olympus IX81 microscope (Olympus, Center Valley, Pa).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head><p><s>GraphPad Prism software (GraphPad Software, La Jolla, Calif) was used for statistical analysis.</s><s>Experiments with 2 groups were analyzed by using an unpaired 2-sided Student t test.</s><s>Comparisons involving multiple groups were analyzed in a 2-stage procedure by means of 1-way ANOVA.</s><s>If the ANOVA indicated a significant difference between groups (P &lt; .05),</s><s>all groups were further compared pairwise by using the Tukey multiple comparison test.</s><s>Nonparametric data were analyzed by using the Kruskal-Wallis test.</s><s>For bar graphs, data are expressed as means 6 SEMs, as indicated in the figure legends.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study approval</head><p><s>Human blood samples were acquired from anonymized patients of the University Clinics of Ulm.</s><s>Patients' consent forms were approved by the appropriate institutional review board of the University Clinics of Ulm.</s></p><p><s>The animal experiments conducted in this study were done in strict accordance with the German regulations of the</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Mechanisms that determine plasma cell lifespan and the duration of humoral immunity</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Amanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Slifka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Rev</title>
		<imprint>
			<biblScope unit="volume">236</biblScope>
			<biblScope unit="page" from="125" to="138" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Long-lived autoreactive plasma cells drive persistent autoimmune inflammation</title>
		<author>
			<persName><forename type="first">F</forename><surname>Hiepe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dorner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Hauser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Hoyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Radbruch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Rheumatol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="170" to="178" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Maintenance of serum antibody levels</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Manz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Hauser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hiepe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Radbruch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="367" to="386" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Regulation of plasma-cell development</title>
		<author>
			<persName><forename type="first">M</forename><surname>Shapiro-Shelef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Calame</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="230" to="242" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Plasma cell differentiation and survival</title>
		<author>
			<persName><forename type="first">D</forename><surname>Tarlinton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Radbruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hiepe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dorner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Immunol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="162" to="169" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Stromal niches, plasma cell differentiation and survival</title>
		<author>
			<persName><forename type="first">K</forename><surname>Moser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tokoyoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Radbruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Maclennan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Manz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Immunol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="265" to="270" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Rotavirus infection in adult small intestine allografts: a clinicopathological study of a cohort of 23 patients</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Adeyi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Bu-Elmagd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Transplant</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="2683" to="2689" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Mechanism of hypergammaglobulinemia by HIV infection: circulating memory B-cell reduction with plasmacytosis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Nagase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Agematsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kitano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Takamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Okubo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Komiyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="250" to="259" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">High incidence of peripheral blood plasmacytosis in patients with dengue virus infection</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Thai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Wismeijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zumpolle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Kersten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>De Vries</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Infect</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1823" to="1828" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Pathological findings in human autoimmune lymphoproliferative syndrome</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Straus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Dale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Fleisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stetler-Stevenson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Strober</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="1541" to="1550" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Systemic lupus erythematosus and Castleman&apos;s disease</title>
		<author>
			<persName><forename type="first">S</forename><surname>Suwannaroj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Elkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Mcmurray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1400" to="1403" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Bone marrow findings in patients with autoimmune liver diseases</title>
		<author>
			<persName><forename type="first">A</forename><surname>Tsikrikoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Rigopoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Zachou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Liaskos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kyriakou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">N</forename><surname>Dalekos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="e416" to="421" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Bone marrow abnormalities in systemic lupus erythematosus with peripheral cytopenia</title>
		<author>
			<persName><forename type="first">C</forename><surname>Wanitpongpun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Teawtrakul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mahakkanukrauh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Siritunyaporn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sirijerachai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chansung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Rheumatol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="825" to="829" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Pathogenesis of myeloma</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Carrasco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Pathol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="249" to="274" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Molecular pathogenesis of multiple myeloma and its premalignant precursor</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Kuehl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Bergsagel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="3456" to="3463" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significance</title>
		<author>
			<persName><forename type="first">D</forename><surname>Zamarin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Devlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Arcila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Landau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lesokhin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lendvai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leukemia</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="2422" to="2424" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Multiple myeloma presenting with an acute bacterial infection</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">N</forename><surname>Kalambokis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Christou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Tsianos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Lab Hematol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="375" to="383" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Infections in patients with multiple myeloma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Anaissie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Hematol</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="277" to="288" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Immunodeficiency and immunotherapy in multiple myeloma</title>
		<author>
			<persName><forename type="first">G</forename><surname>Pratt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Goodyear</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Moss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="563" to="579" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Prophylactic use of antibiotics and immunisations in patients with SLE</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Gilliland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Tsokos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="191" to="192" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Immunodeficiency and autoimmunity: lessons from systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Grammatikos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Tsokos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Mol Med</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="101" to="108" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Diseases associated with immunosuppression</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Heise</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health Perspect</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="9" to="19" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Fessler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Best Pract Res Clin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="281" to="291" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Infections and SLE</title>
		<author>
			<persName><forename type="first">G</forename><surname>Zandman-Goddard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shoenfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Autoimmunity</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="473" to="485" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Plasma cells negatively regulate the follicular helper T cell program</title>
		<author>
			<persName><forename type="first">N</forename><surname>Pelletier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Heyzer-Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Urich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fazilleau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Heyzer-Williams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1110" to="1118" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgammat and Ahr that leads to IL-17 production by activated B cells</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Bermejo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gorosito-Serran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Costa-Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Vesely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Sather</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="514" to="522" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases</title>
		<author>
			<persName><forename type="first">P</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Roch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Lampropoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Stervbo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Hilgenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">507</biblScope>
			<biblScope unit="page" from="366" to="370" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Matsumoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Baba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yokota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nishikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ohkawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kayama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1040" to="1051" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">IL-10 in myeloma cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Otsuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sakaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Uno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fujii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wada</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leuk Lymphoma</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="969" to="974" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Influence of Atg5 Mutation in SLE Depends on Functional IL-10 Genotype</title>
		<author>
			<persName><forename type="first">P</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Onso-Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rodriguez-Carrio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Suarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e78756</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Neutrophil function in systemic lupus erythematosus and other collagen diseases</title>
		<author>
			<persName><forename type="first">H</forename><surname>Al-Hadithy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Isenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">E</forename><surname>Addison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Goldstone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Snaith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="33" to="38" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Neutrophil function: from mechanisms to disease</title>
		<author>
			<persName><forename type="first">B</forename><surname>Amulic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cazalet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Hayes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Metzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zychlinsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="459" to="489" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Neutrophil recruitment and function in health and inflammation</title>
		<author>
			<persName><forename type="first">E</forename><surname>Kolaczkowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kubes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="159" to="175" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Neutrophil extracellular traps kill bacteria</title>
		<author>
			<persName><forename type="first">V</forename><surname>Brinkmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Reichard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Goosmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fauler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Uhlemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Weiss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">303</biblScope>
			<biblScope unit="page" from="1532" to="1535" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Tsuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hanafusa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Herndon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Suzuki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="215" to="226" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Neutrophils come of age in chronic inflammation</title>
		<author>
			<persName><forename type="first">S</forename><surname>Caielli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Banchereau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pascual</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Immunol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="671" to="677" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Karsten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kohl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunobiology</title>
		<imprint>
			<biblScope unit="volume">217</biblScope>
			<biblScope unit="page" from="1067" to="1079" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Chiriac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Roesler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sindrilaru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Scharffetter-Kochanek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zillikens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sitaru</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pathol</title>
		<imprint>
			<biblScope unit="volume">212</biblScope>
			<biblScope unit="page" from="56" to="65" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Karsten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Pandey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Figge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kilchenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rosas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1401" to="1406" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Deletion of Syk in neutrophils prevents immune complex arthritis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Elliott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Van Ziffle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Scapini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Locksley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Lowell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="page" from="4319" to="4330" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">C5a initiates the inflammatory cascade in immune complex peritonitis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Godau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Heller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hawlisch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Trappe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Howells</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Best</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="page" from="3437" to="3445" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Persistent autoantibody-production by intermediates between short-and longlived plasma cells in inflamed lymph nodes of experimental epidermolysis bullosa acquisita</title>
		<author>
			<persName><forename type="first">B</forename><surname>Tiburzy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Szyska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Iwata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Chrobok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Kulkarni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hirose</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e83631</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">O</forename><surname>Hofgaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Jodal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bommert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Huard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Caers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Carlsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e51892</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Following in real time the impact of pneumococcal virulence factors in an acute mouse pneumonia model using bioluminescent bacteria</title>
		<author>
			<persName><forename type="first">M</forename><surname>Saleh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Abdullah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kohler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pribyl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Jensch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Vis Exp</title>
		<imprint>
			<date type="published" when="2014">2014. e51174</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Impact of glutamine transporters on pneumococcal fitness under infection-related conditions</title>
		<author>
			<persName><forename type="first">T</forename><surname>Hartel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Koedel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rohde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Petruschka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hammerschmidt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Immun</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="44" to="58" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">PavB is a surface-exposed adhesin of Streptococcus pneumoniae contributing to nasopharyngeal colonization and airways infections</title>
		<author>
			<persName><forename type="first">I</forename><surname>Jensch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gamez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rothe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ebert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fulde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Somplatzki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Microbiol</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="22" to="43" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Nonredundant roles for B cell-derived IL-10 in immune counter-regulation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Madan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Demircik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Surianarayanan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Divanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Trompette</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="2312" to="2320" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Finkelman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Madden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Boiani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Katona</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="page" from="1235" to="1244" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Vasconcellos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Rosser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tulone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Munoz-Suano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kamanaka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="page" from="5569" to="5579" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Eosinophils and megakaryocytes support the early growth of murine MOPC315 myeloma cells in their bone marrow niches</title>
		<author>
			<persName><forename type="first">D</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Winter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hartig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Siebels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Szyska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tiburzy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e109018</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Homing and adhesion patterns determine the cellular composition of the bone marrow plasma cell niche</title>
		<author>
			<persName><forename type="first">E</forename><surname>Belnoue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tougne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Rochat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Pinschewer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Siegrist</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="page" from="1283" to="1291" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow</title>
		<author>
			<persName><forename type="first">O</forename><surname>Winter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Moser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mohr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zotos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kaminski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Szyska</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="1867" to="1875" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Recke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bieber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Marques</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Banczyk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="167" to="176" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Chollet-Martin S. Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Vicioso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Garaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Reglier-Poupet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lebeaut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Gougerot-Pocidalo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Cytokine Netw</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="247" to="253" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Immunopathology of Schistosoma mansoni infection</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Boros</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Rev</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="250" to="269" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Grau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Frei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Piguet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fontana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Heremans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Billiau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="page" from="1505" to="1508" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Self-reactivities to the non-erythroid alpha spectrin correlate with cerebral malaria in Gabonese children</title>
		<author>
			<persName><forename type="first">V</forename><surname>Guiyedi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chanseaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fesel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Snounou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Rousselle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">e389</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Antibody-dependent enhancement of hepatitis C virus infection</title>
		<author>
			<persName><forename type="first">K</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ait-Goughoulte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">Y</forename><surname>Keck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Foung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="2140" to="2149" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Infection and glomerulonephritis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Naicker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fabian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Naidoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wadee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Paget</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Goetsch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Immunopathol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="397" to="414" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Development of autoantibodies before the clinical onset of systemic lupus erythematosus</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Arbuckle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Mcclain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Rubertone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Scofield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Dennis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>James</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">349</biblScope>
			<biblScope unit="page" from="1526" to="1533" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice</title>
		<author>
			<persName><forename type="first">P</forename><surname>Scapini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lamagna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Defranco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="E823" to="832" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Fas(lpr) mice</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Teichmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kashgarian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Weaver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Roers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Shlomchik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="page" from="678" to="685" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Lipsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="764" to="766" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-beta1 gene therapy using attenuated Salmonella typhimurium as gene carrier</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Huggins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lindop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">I</forename><surname>Stott</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lupus</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="29" to="38" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Barr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Lampropoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Roch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lawrie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">209</biblScope>
			<biblScope unit="page" from="1001" to="1010" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: a feedback regulation of Th1 development</title>
		<author>
			<persName><forename type="first">J</forename><surname>Skok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Poudrier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page" from="4284" to="4291" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Plasma cells in immunopathology: concepts and therapeutic strategies</title>
		<author>
			<persName><forename type="first">B</forename><surname>Tiburzy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Kulkarni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Hauser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Abram</forename><forename type="middle">M</forename><surname>Manz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Immunopathol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="277" to="288" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">The neutrophil: one of the cellular targets of interleukin-10</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Cassatella</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Clin Lab Res</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="148" to="161" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Regulation and functions of the IL-10 family of cytokines in inflammation and disease</title>
		<author>
			<persName><forename type="first">W</forename><surname>Ouyang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Crellin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Valdez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Hymowitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="71" to="109" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Persistent autoantibody-production by intermediates between short-and long-lived plasma cells in inflamed lymph nodes of experimental epidermolysis bullosa acquisita</title>
		<author>
			<persName><surname>References E1</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tiburzy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Szyska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Iwata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Chrobok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Kulkarni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hirose</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e83631</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
